Cargando…

Neuropsychological Profiles in Mild Cognitive Impairment due to Alzheimer’s and Parkinson’s Diseases

Background: Neuropsychological comparisons between patients with mild cognitive impairment due to Parkinson’s disease (MCI-PD) and Alzheimer’s disease (MCI-AD) is mostly based on indirect comparison of patients with these disorders and normal controls (NC). Objective: The focus of this study was to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hessen, Erik, Stav, Ane Løvli, Auning, Eirik, Selnes, Per, Blomsø, Linn, Holmeide, Cathrine Emilie, Johansen, Krisztina Kunszt, Eliassen, Carl Fredrik, Reinvang, Ivar, Fladby, Tormod, Aarsland, Dag
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	IOS Press 2016
Materias:	Research Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4927809/ https://www.ncbi.nlm.nih.gov/pubmed/27061068 http://dx.doi.org/10.3233/JPD-150761

Ejemplares similares

Hippocampal subfield atrophy in relation to cerebrospinal fluid biomarkers and cognition in early Parkinson’s disease: a cross-sectional study
por: Stav, Ane Løvli, et al.
Publicado: (2016)

Impaired synaptic function is linked to cognition in Parkinson's disease
por: Selnes, Per, et al.
Publicado: (2017)

Correlates of Subjective and Mild Cognitive Impairment: Depressive Symptoms and CSF Biomarkers
por: Grambaite, Ramune, et al.
Publicado: (2013)

Biomarkers in subtypes of mild cognitive impairment and subjective cognitive decline
por: Eliassen, Carl F., et al.
Publicado: (2017)

White matter integrity and cognition in Parkinson's disease: a cross-sectional study
por: Auning, Eirik, et al.
Publicado: (2014)

Detecting At-Risk Alzheimer’s Disease Cases
por: Fladby, Tormod, et al.
Publicado: (2017)

In Brief Neuropsychological Assessment, Amnestic Mild Cognitive Impairment (MCI) Is associated with Cerebrospinal Fluid Biomarkers for Cognitive Decline in Contrast to the Prevailing NIA-AA MCI Criterion
por: Hessen, Erik, et al.
Publicado: (2019)

The Combination of Dysexecutive and Amnestic Deficits Strongly Predicts Conversion to Dementia in Young Mild Cognitive Impairment Patients: A Report from the Gothenburg-Oslo MCI Study
por: Hessen, Erik, et al.
Publicado: (2014)

Cerebrospinal fluid markers for synaptic function and Alzheimer type changes in late life depression
por: Siafarikas, Nikias, et al.
Publicado: (2021)

Author Correction: Cerebrospinal fluid markers for synaptic function and Alzheimer type changes in late life depression
por: Siafarikas, Nikias, et al.
Publicado: (2022)

Cognitive Deficits in Chronic Stroke Patients: Neuropsychological Assessment, Depression, and Self-Reports
por: Nakling, Arne E., et al.
Publicado: (2017)

Cerebrospinal fluid neurogranin/β-site APP-cleaving enzyme 1 predicts cognitive decline in preclinical Alzheimer's disease
por: Kirsebom, Bjørn-Eivind, et al.
Publicado: (2018)

Screening for Alzheimer’s Disease: Cognitive Impairment in Self-Referred and Memory Clinic-Referred Patients
por: Kirsebom, Bjørn-Eivind, et al.
Publicado: (2017)

Subjective Cognitive Impairment Is a Predominantly Benign Condition in Memory Clinic Patients Followed for 6 Years: The Gothenburg-Oslo MCI Study
por: Hessen, Erik, et al.
Publicado: (2017)

FLAME: A computerized neuropsychological composite for trials in early dementia
por: Brooker, Helen, et al.
Publicado: (2020)

Amyloid Plaques and Symptoms of Depression Links to Medical Help-Seeking due to Subjective Cognitive Decline
por: Espenes, Ragna, et al.
Publicado: (2020)

Association of Klotho Protein Levels and KL-VS Heterozygosity With Alzheimer Disease and Amyloid and Tau Burden
por: Grøntvedt, Gøril Rolfseng, et al.
Publicado: (2022)

[(18)F]-Flutemetamol Uptake in Cortex and White Matter: Comparison with Cerebrospinal Fluid Biomarkers and [(18)F]-Fludeoxyglucose
por: Kalheim, Lisa Flem, et al.
Publicado: (2018)

Glial activation and inflammation along the Alzheimer’s disease continuum
por: Nordengen, Kaja, et al.
Publicado: (2019)

Brain amyloid and vascular risk are related to distinct white matter hyperintensity patterns
por: Pålhaugen, Lene, et al.
Publicado: (2020)

Amyloid Dysmetabolism Relates to Reduced Glucose Uptake in White Matter Hyperintensities
por: Kalheim, Lisa Flem, et al.
Publicado: (2016)

Stable cerebrospinal fluid neurogranin and β-site amyloid precursor protein cleaving enzyme 1 levels differentiate predementia Alzheimer’s disease patients
por: Kirsebom, Bjørn Eivind, et al.
Publicado: (2022)

Effects of cerebrovascular disease on amyloid precursor protein metabolites in cerebrospinal fluid
por: Selnes, Per, et al.
Publicado: (2010)

Clinical and Neuropsychological Differences between Mild Parkinson's Disease Dementia and Dementia with Lewy Bodies
por: Petrova, Mariya, et al.
Publicado: (2015)

CSF, Blood, and MRI Biomarkers in Skogholt’s Disease—A Rare Neurodegenerative Disease in a Norwegian Kindred
por: Aspli, Klaus Thanke, et al.
Publicado: (2023)

Diffusion tensor and restriction spectrum imaging reflect different aspects of neurodegeneration in Parkinson’s disease
por: Hope, Tuva R., et al.
Publicado: (2019)

Segmenting white matter hyperintensities on isotropic three-dimensional Fluid Attenuated Inversion Recovery magnetic resonance images: Assessing deep learning tools on a Norwegian imaging database
por: Røvang, Martin Soria, et al.
Publicado: (2023)

Phenotype‐informed polygenic risk scores are associated with worse outcome in individuals at risk of Alzheimer's disease
por: Nordengen, Kaja, et al.
Publicado: (2022)

European Clinical Neuropsychology: Role in Healthcare and Access to Neuropsychological Services
por: Kasten, Erich, et al.
Publicado: (2021)

Effects of Purified Anthocyanins in People at Risk for Dementia: Study Protocol for a Phase II Randomized Controlled Trial
por: Khalifa, Khadija, et al.
Publicado: (2020)

Successful syllable detection in aphasia despite processing impairments as revealed by event-related potentials
por: Becker, Frank, et al.
Publicado: (2007)

Altered DNA base excision repair profile in brain tissue and blood in Alzheimer’s disease
por: Lillenes, Meryl S., et al.
Publicado: (2016)

Executive Dysfunction in MCI: Subtype or Early Symptom
por: Reinvang, Ivar, et al.
Publicado: (2012)

The neuropsychological profile of work addiction
por: Berta, Krisztina, et al.
Publicado: (2023)

Cerebrospinal fluid markers in Creutzfeldt-Jakob disease
por: Skinningsrud, Anders, et al.
Publicado: (2008)

Cerebrospinal Fluid Levels of Amyloid Beta 1-43 Mirror 1-42 in Relation to Imaging Biomarkers of Alzheimer’s Disease
por: Almdahl, Ina S., et al.
Publicado: (2017)

Growth, stoichiometry and cell size; temperature and nutrient responses in haptophytes
por: Skau, Lars Fredrik, et al.
Publicado: (2017)

Core Competencies in Clinical Neuropsychology as a Training Model in Europe
por: Kosmidis, Mary H., et al.
Publicado: (2022)

A Case of Parkinson's Disease with No Lewy Body Pathology due to a Homozygous Exon Deletion in Parkin
por: Johansen, Krisztina Kunszt, et al.
Publicado: (2018)

Efficacy and Safety of Analgesic Treatment for Depression in People with Advanced Dementia: Randomised, Multicentre, Double-Blind, Placebo-Controlled Trial (DEP.PAIN.DEM)
por: Erdal, Ane, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_bangiq14esg113smih2n76oobb